Side-by-side financials for CRIS and RVMD. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CRIS | RVMD |
|---|---|---|
| Market cap | - | $30.74 B |
| US-listed rank | - | #453 |
| Revenue (latest FY) | $9.44M | $0.00 |
| Net income (latest FY) | -$7.58M | -$1.13B |
| Net margin | -80.3% | - |
| SEC filings | 1,001 | 782 |
In their latest fiscal years, CURIS INC reported $9.44M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: CURIS INC and Revolution Medicines, Inc., or browse the full rankings.